Kendall Capital Partners β Full Portfolio
13 tracked investments Β· listed companies and verified rows first
BiotechCambridge, US
Thomas A. Collet(Executive Officer, Director)Carlo Traverso Giovanni(Director)
BoardJoshua Korzenik(Director)
Board seatRobert LangerΒ· per SEC Form D Β· $1M raise Β· filed Aug 2023
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
Board seatGeorge M. ChurchΒ· per SEC Form D Β· $3M raise Β· filed Aug 2016
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPKhosla VenturesOUP (Osage University Partners)b2venture
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)Sarindr Bhumiratana(Co-Founder)Gordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardDavid Zhu(Director)
Board seatRobert LangerΒ· per SEC Form D
Co-investorsBeresford VenturesEMV CapitalHackensack Meridian Health Bear's DenPlum Alley InvestmentsTachyon VenturesTech Council Ventures
BiotechWoburn, US
David Lucchino(Executive Officer, Director)Christopher R. Loose(Executive Officer)
BoardMarc Kozin(Director)Marc Cohen(Director)Timothy Barberich(Director)
Board seatRobert LangerΒ· per SEC Form D Β· $62M raise Β· filed Jul 2019
Co-investorsvenBio PartnersAlexandria
BiotechWatertown, US
Carlo Giovanni Traverso(Director)Amy W. Schulman(Executive Officer, Director)inRobert S. Langer(Director)
BoardZafi Avnur(Director)Edmund Harrigan(Director)Catherine Reynolds(Director)
Board seatRobert LangerΒ· per SEC Form D Β· $23.1M raise Β· filed Apr 2017
Co-investorsBill & Melinda Gates FoundationPolaris Partners
HealthtechLexington, US
Robert S. Langer(Director)Michael J. Cima(Director)David Neafus(Executive Officer)Cheryl R. Blanchard(Executive Officer, Director)Robert Farra(Executive Officer)
BoardTerrance G. McGuire(Director)
Board seatRobert LangerΒ· per SEC Form D Β· $18.6M raise Β· filed Jun 2015
Co-investorsPolaris Partners
A biotech company developing a multi-layered polymer delivery system for sustained-release vaccine and medication administration via single injection.
Cambridge, US
Board seatRobert LangerΒ· per SEC Form D
BiotechCambridge, US
Torben Straight Nissen(Executive Officer, Director)Joanne Protano(Executive Officer)David Epstein(Director)Harvey F. Lodish(Director)Michael Rosenblatt(Director)Roger Pomerantz(Director)
Board seatRobert LangerΒ· per SEC Form D Β· $120M raise Β· filed Jun 2017
Co-investorsFlagship Pioneering
BiotechWatertown, US
Omid Farokhzad(Director)Robert S. Langer, Jr.(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)Richard Wooster(Executive Officer)Omid C. Farokhzad(Director)
Board seatRobert LangerΒ· per SEC Form D Β· $38M raise Β· filed Feb 2017
Co-investors+ND Capital
Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWoodland Hills, US
Kaushal Solanki(Director)Gaurav Agarwal(Executive Officer, Director)
BoardMads Dall(Director)Zina Affas Besse(Director)Marie-Louise Little(Director)
Rejuvenate Bio is a biotechnology company developing gene therapies aimed at treating age-related diseases, with a pipeline that includes a canine mitral valve disease (MVD) program.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)Daniel Oliver(CEO, Co-Founder)George Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)
BoardDavid Zhu(Director)
Co-investorsCompanion FundConnecticut InnovationsKdT Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.